Mandate

Vinge has advised 4 to 1 Investment, a company jointly held by Första AP-fonden, Andra AP-fonden, Tredje AP-fonden and Fjärde AP-fonden, in connection with an investment in Northvolt

Northvolt has carried out a USD 2.75 billion private placement to finance further battery cell production capacity and R&D efforts in order to meet the increasing demand of customers.

The private placement was co-led by new investors AP funds 1-4, via the co-owned company, 4 to 1 Investments, and OMERS, one of Canada’s largest defined benefit pension plans, alongside existing investors such as Goldman Sachs Asset Management and Volkswagen Group. Northvolt is conducting business within lithium ion battery production with the aim to establish large-scale battery factories.

Vinge’s team consisted primarily of Charlotte Levin, Kristina Ekberg, Ulrich Ziche, Joel Wahlberg, Joel Magnusson and Linnea Petersson

 

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025